SCHEMBL23849997

SCHEMBL23849997

CC(C)(C)OC(=O)N1CC2(C1)CN(c1cccc(C(F)(F)F)c1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 7/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ MGLL Q99685 1/20 0.46
▸ ABHD6 Q9BV23 1/20 0.46
▸ TSHR P16473 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ GPR119 Q8TDV5 1/20 0.46
▸ HTT P42858 3/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21542308 0.84 ALDH1A1 (0.65) POLBALDH1A1LMNAMAPK1RAB9A
SCHEMBL30830782 0.83 GPR119 (0.47) ALDH1A1MAPK1HPGDGPR119HSD17B10
SCHEMBL25965843 0.83 GPR119 (0.47) ALDH1A1MAPK1HPGDGPR119HSD17B10
SCHEMBL13015628 0.82 EIF2AK4 (0.44) TSHRMAPTGPR119CYP2C9
SCHEMBL10111760 0.82 GPR119 (0.59) ALDH1A1LMNAMAPK1TSHRMAPT
SCHEMBL30978987 0.81 GPR119 (0.48) ALDH1A1MAPK1HPGDGPR119HSD17B10
SCHEMBL23576738 0.81 GPR119 (0.48) ALDH1A1MAPK1HPGDGPR119HSD17B10
SCHEMBL5235386 0.80 ALDH1A1 (0.60) POLBALDH1A1LMNAMAPK1RAB9A
SCHEMBL25168131 0.80 POLB (0.55) POLBLMNATSHRMAPTGPR119
SCHEMBL30410566 0.80 POLB (0.55) POLBLMNATSHRMAPTGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577257-B2 Heterocyclic compounds HOFFMANN-LA ROCHE INC. (US) 2026-03-17 — — US disclosed
EP-3883936-B1 NEW HETEROCYCLIC COMPOUNDS HOFFMANN LA ROCHE (CH) 2023-07-12 — — EP disclosed
US-20210387999-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-12-16 — — US disclosed
EP-3883936-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2021-09-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387999-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 POLB 936/4885ALDH1A1 492/4885LMNA 197/4885
US-12577257-B2 Heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CBR3 POLB 2558/4885ALDH1A1 1116/4885LMNA 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback